{{Rsnum
|rsid=12105918
|Gene=ZEB2
|Chromosome=2
|position=144450626
|Orientation=plus
|GMAF=0.05877
|Gene_s=ZEB2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 8.0 | 92.0
| HCB | 0.7 | 14.6 | 84.7
| JPT | 0.9 | 20.4 | 78.8
| YRI | 1.4 | 10.9 | 87.8
| ASW | 0.0 | 7.0 | 93.0
| CHB | 0.7 | 14.6 | 84.7
| CHD | 0.9 | 21.1 | 78.0
| GIH | 1.0 | 12.9 | 86.1
| LWK | 0.9 | 10.9 | 88.2
| MEX | 0.0 | 3.4 | 96.6
| MKK | 1.3 | 15.4 | 83.3
| TSI | 0.0 | 8.8 | 91.2
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23184150
  |Trait=Renal cell carcinoma
  |Title=Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer.
  |RiskAllele=
  |Pval=2E-8
  |OR=1.45
  |ORtxt=[1.20-1.75]
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}